HEADER TRANSFERASE 20-AUG-20 7A55 TITLE STRUCTURE OF DYRK1A IN COMPLEX WITH COMPOUND 8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE COMPND 3 1A; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: DUAL SPECIFICITY YAK1-RELATED KINASE,HP86,PROTEIN KINASE COMPND 6 MINIBRAIN HOMOLOG,HMNB; COMPND 7 EC: 2.7.12.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DYRK1A, DYRK, MNB, MNBH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: PLYSS KEYWDS SERINE/THREONINE-PROTEIN KINASE, PHOSPHOPROTEIN, KINASE, SBDD, FBLD, KEYWDS 2 SMALL MOLECULE INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.DOKURNO,A.E.SURGENOR,R.E.HUBBARD REVDAT 3 31-JAN-24 7A55 1 REMARK REVDAT 2 21-JUL-21 7A55 1 JRNL REVDAT 1 30-JUN-21 7A55 0 JRNL AUTH D.LEE WALMSLEY,J.B.MURRAY,P.DOKURNO,A.J.MASSEY,K.BENWELL, JRNL AUTH 2 A.FIUMANA,N.FOLOPPE,S.RAY,J.SMITH,A.E.SURGENOR,T.EDMONDS, JRNL AUTH 3 D.DEMARLES,M.BURBRIDGE,F.CRUZALEGUI,A.KOTSCHY,R.E.HUBBARD JRNL TITL FRAGMENT-DERIVED SELECTIVE INHIBITORS OF DUAL-SPECIFICITY JRNL TITL 2 KINASES DYRK1A AND DYRK1B. JRNL REF J.MED.CHEM. V. 64 8971 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34143631 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00024 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 36636 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1912 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.32 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5028 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.27 REMARK 3 BIN R VALUE (WORKING SET) : 0.3250 REMARK 3 BIN FREE R VALUE SET COUNT : 244 REMARK 3 BIN FREE R VALUE : 0.3460 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5545 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 269 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.16000 REMARK 3 B22 (A**2) : -1.87000 REMARK 3 B33 (A**2) : 0.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.72000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.271 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.204 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.190 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.436 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.933 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5706 ; 0.007 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 5315 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7705 ; 1.500 ; 1.644 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12328 ; 1.281 ; 1.580 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 677 ; 6.450 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 304 ;35.090 ;22.401 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1023 ;16.218 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;20.784 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 705 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6293 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1221 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7A55 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1292110862. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9796 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38587 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.11400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.79500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2VX3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES BUFFER AT PH 6.5, 12% REMARK 280 PEG3350, 0.2M MGCL2, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.35050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 104 REMARK 465 HIS A 105 REMARK 465 HIS A 106 REMARK 465 HIS A 107 REMARK 465 HIS A 108 REMARK 465 HIS A 109 REMARK 465 HIS A 110 REMARK 465 SER A 111 REMARK 465 SER A 112 REMARK 465 GLY A 113 REMARK 465 VAL A 114 REMARK 465 ASP A 115 REMARK 465 LEU A 116 REMARK 465 GLY A 117 REMARK 465 THR A 118 REMARK 465 GLU A 119 REMARK 465 ASN A 120 REMARK 465 LEU A 121 REMARK 465 TYR A 122 REMARK 465 PHE A 123 REMARK 465 GLN A 124 REMARK 465 SER A 125 REMARK 465 MET A 126 REMARK 465 SER A 127 REMARK 465 SER A 128 REMARK 465 HIS A 129 REMARK 465 LYS A 130 REMARK 465 LYS A 131 REMARK 465 GLU A 132 REMARK 465 ARG A 133 REMARK 465 LYS A 134 REMARK 465 VAL A 135 REMARK 465 THR A 408 REMARK 465 LYS A 409 REMARK 465 ASP A 410 REMARK 465 GLY A 411 REMARK 465 LYS A 412 REMARK 465 ARG A 413 REMARK 465 THR A 482 REMARK 465 ALA A 483 REMARK 465 ASP A 484 REMARK 465 GLU A 485 REMARK 465 MET B 104 REMARK 465 HIS B 105 REMARK 465 HIS B 106 REMARK 465 HIS B 107 REMARK 465 HIS B 108 REMARK 465 HIS B 109 REMARK 465 HIS B 110 REMARK 465 SER B 111 REMARK 465 SER B 112 REMARK 465 GLY B 113 REMARK 465 VAL B 114 REMARK 465 ASP B 115 REMARK 465 LEU B 116 REMARK 465 GLY B 117 REMARK 465 THR B 118 REMARK 465 GLU B 119 REMARK 465 ASN B 120 REMARK 465 LEU B 121 REMARK 465 TYR B 122 REMARK 465 PHE B 123 REMARK 465 GLN B 124 REMARK 465 SER B 125 REMARK 465 MET B 126 REMARK 465 SER B 127 REMARK 465 SER B 128 REMARK 465 HIS B 129 REMARK 465 LYS B 130 REMARK 465 LYS B 131 REMARK 465 GLU B 132 REMARK 465 ARG B 133 REMARK 465 LYS B 407 REMARK 465 THR B 408 REMARK 465 LYS B 409 REMARK 465 ASP B 410 REMARK 465 GLY B 411 REMARK 465 LYS B 412 REMARK 465 ARG B 413 REMARK 465 THR B 482 REMARK 465 ALA B 483 REMARK 465 ASP B 484 REMARK 465 GLU B 485 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 136 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 317 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 407 CG CD CE NZ REMARK 470 LYS A 480 CD CE NZ REMARK 470 LYS A 481 CG CD CE NZ REMARK 470 LYS B 154 CG CD CE NZ REMARK 470 GLU B 216 CG CD OE1 OE2 REMARK 470 ARG B 317 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 716 O HOH A 718 1.88 REMARK 500 O HOH B 692 O HOH B 719 1.88 REMARK 500 O HOH B 669 O HOH B 735 2.02 REMARK 500 O HOH B 678 O HOH B 717 2.04 REMARK 500 OE1 GLN B 199 O HOH B 601 2.06 REMARK 500 O HOH B 655 O HOH B 738 2.07 REMARK 500 O HOH A 647 O HOH A 706 2.15 REMARK 500 O HOH B 710 O HOH B 728 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 718 O HOH B 751 1455 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 158 -53.17 -134.13 REMARK 500 ASP A 214 56.46 -93.65 REMARK 500 LEU A 241 -163.70 -104.11 REMARK 500 SER A 242 -147.16 -116.27 REMARK 500 LEU A 281 -65.93 -90.99 REMARK 500 CYS A 286 -1.02 82.56 REMARK 500 ASP A 287 45.53 -151.82 REMARK 500 ASP A 307 73.01 70.04 REMARK 500 GLN A 323 145.82 73.06 REMARK 500 SER A 362 68.19 -102.54 REMARK 500 ARG B 158 -52.31 -147.04 REMARK 500 ASP B 162 -62.54 -96.06 REMARK 500 LEU B 241 -163.70 -113.96 REMARK 500 SER B 242 -153.48 -114.92 REMARK 500 THR B 278 130.47 -39.29 REMARK 500 LEU B 281 -69.14 -98.95 REMARK 500 ASP B 287 41.35 -150.23 REMARK 500 ASP B 307 85.31 73.14 REMARK 500 GLN B 323 147.59 76.28 REMARK 500 ASP B 339 -159.02 -139.76 REMARK 500 SER B 362 59.28 -95.63 REMARK 500 GLU B 396 -166.85 -127.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7A4O RELATED DB: PDB REMARK 900 RELATED ID: 7A4R RELATED DB: PDB REMARK 900 RELATED ID: 7A4S RELATED DB: PDB REMARK 900 RELATED ID: 7A4W RELATED DB: PDB REMARK 900 RELATED ID: 7A4Z RELATED DB: PDB REMARK 900 RELATED ID: 7A51 RELATED DB: PDB REMARK 900 RELATED ID: 7A52 RELATED DB: PDB REMARK 900 RELATED ID: 7A53 RELATED DB: PDB DBREF 7A55 A 127 485 UNP Q13627 DYR1A_HUMAN 127 485 DBREF 7A55 B 127 485 UNP Q13627 DYR1A_HUMAN 127 485 SEQADV 7A55 MET A 104 UNP Q13627 INITIATING METHIONINE SEQADV 7A55 HIS A 105 UNP Q13627 EXPRESSION TAG SEQADV 7A55 HIS A 106 UNP Q13627 EXPRESSION TAG SEQADV 7A55 HIS A 107 UNP Q13627 EXPRESSION TAG SEQADV 7A55 HIS A 108 UNP Q13627 EXPRESSION TAG SEQADV 7A55 HIS A 109 UNP Q13627 EXPRESSION TAG SEQADV 7A55 HIS A 110 UNP Q13627 EXPRESSION TAG SEQADV 7A55 SER A 111 UNP Q13627 EXPRESSION TAG SEQADV 7A55 SER A 112 UNP Q13627 EXPRESSION TAG SEQADV 7A55 GLY A 113 UNP Q13627 EXPRESSION TAG SEQADV 7A55 VAL A 114 UNP Q13627 EXPRESSION TAG SEQADV 7A55 ASP A 115 UNP Q13627 EXPRESSION TAG SEQADV 7A55 LEU A 116 UNP Q13627 EXPRESSION TAG SEQADV 7A55 GLY A 117 UNP Q13627 EXPRESSION TAG SEQADV 7A55 THR A 118 UNP Q13627 EXPRESSION TAG SEQADV 7A55 GLU A 119 UNP Q13627 EXPRESSION TAG SEQADV 7A55 ASN A 120 UNP Q13627 EXPRESSION TAG SEQADV 7A55 LEU A 121 UNP Q13627 EXPRESSION TAG SEQADV 7A55 TYR A 122 UNP Q13627 EXPRESSION TAG SEQADV 7A55 PHE A 123 UNP Q13627 EXPRESSION TAG SEQADV 7A55 GLN A 124 UNP Q13627 EXPRESSION TAG SEQADV 7A55 SER A 125 UNP Q13627 EXPRESSION TAG SEQADV 7A55 MET A 126 UNP Q13627 EXPRESSION TAG SEQADV 7A55 MET B 104 UNP Q13627 INITIATING METHIONINE SEQADV 7A55 HIS B 105 UNP Q13627 EXPRESSION TAG SEQADV 7A55 HIS B 106 UNP Q13627 EXPRESSION TAG SEQADV 7A55 HIS B 107 UNP Q13627 EXPRESSION TAG SEQADV 7A55 HIS B 108 UNP Q13627 EXPRESSION TAG SEQADV 7A55 HIS B 109 UNP Q13627 EXPRESSION TAG SEQADV 7A55 HIS B 110 UNP Q13627 EXPRESSION TAG SEQADV 7A55 SER B 111 UNP Q13627 EXPRESSION TAG SEQADV 7A55 SER B 112 UNP Q13627 EXPRESSION TAG SEQADV 7A55 GLY B 113 UNP Q13627 EXPRESSION TAG SEQADV 7A55 VAL B 114 UNP Q13627 EXPRESSION TAG SEQADV 7A55 ASP B 115 UNP Q13627 EXPRESSION TAG SEQADV 7A55 LEU B 116 UNP Q13627 EXPRESSION TAG SEQADV 7A55 GLY B 117 UNP Q13627 EXPRESSION TAG SEQADV 7A55 THR B 118 UNP Q13627 EXPRESSION TAG SEQADV 7A55 GLU B 119 UNP Q13627 EXPRESSION TAG SEQADV 7A55 ASN B 120 UNP Q13627 EXPRESSION TAG SEQADV 7A55 LEU B 121 UNP Q13627 EXPRESSION TAG SEQADV 7A55 TYR B 122 UNP Q13627 EXPRESSION TAG SEQADV 7A55 PHE B 123 UNP Q13627 EXPRESSION TAG SEQADV 7A55 GLN B 124 UNP Q13627 EXPRESSION TAG SEQADV 7A55 SER B 125 UNP Q13627 EXPRESSION TAG SEQADV 7A55 MET B 126 UNP Q13627 EXPRESSION TAG SEQRES 1 A 382 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 382 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER SER HIS SEQRES 3 A 382 LYS LYS GLU ARG LYS VAL TYR ASN ASP GLY TYR ASP ASP SEQRES 4 A 382 ASP ASN TYR ASP TYR ILE VAL LYS ASN GLY GLU LYS TRP SEQRES 5 A 382 MET ASP ARG TYR GLU ILE ASP SER LEU ILE GLY LYS GLY SEQRES 6 A 382 SER PHE GLY GLN VAL VAL LYS ALA TYR ASP ARG VAL GLU SEQRES 7 A 382 GLN GLU TRP VAL ALA ILE LYS ILE ILE LYS ASN LYS LYS SEQRES 8 A 382 ALA PHE LEU ASN GLN ALA GLN ILE GLU VAL ARG LEU LEU SEQRES 9 A 382 GLU LEU MET ASN LYS HIS ASP THR GLU MET LYS TYR TYR SEQRES 10 A 382 ILE VAL HIS LEU LYS ARG HIS PHE MET PHE ARG ASN HIS SEQRES 11 A 382 LEU CYS LEU VAL PHE GLU MET LEU SER TYR ASN LEU TYR SEQRES 12 A 382 ASP LEU LEU ARG ASN THR ASN PHE ARG GLY VAL SER LEU SEQRES 13 A 382 ASN LEU THR ARG LYS PHE ALA GLN GLN MET CYS THR ALA SEQRES 14 A 382 LEU LEU PHE LEU ALA THR PRO GLU LEU SER ILE ILE HIS SEQRES 15 A 382 CYS ASP LEU LYS PRO GLU ASN ILE LEU LEU CYS ASN PRO SEQRES 16 A 382 LYS ARG SER ALA ILE LYS ILE VAL ASP PHE GLY SER SER SEQRES 17 A 382 CYS GLN LEU GLY GLN ARG ILE TYR GLN PTR ILE GLN SER SEQRES 18 A 382 ARG PHE TYR ARG SER PRO GLU VAL LEU LEU GLY MET PRO SEQRES 19 A 382 TYR ASP LEU ALA ILE ASP MET TRP SER LEU GLY CYS ILE SEQRES 20 A 382 LEU VAL GLU MET HIS THR GLY GLU PRO LEU PHE SER GLY SEQRES 21 A 382 ALA ASN GLU VAL ASP GLN MET ASN LYS ILE VAL GLU VAL SEQRES 22 A 382 LEU GLY ILE PRO PRO ALA HIS ILE LEU ASP GLN ALA PRO SEQRES 23 A 382 LYS ALA ARG LYS PHE PHE GLU LYS LEU PRO ASP GLY THR SEQRES 24 A 382 TRP ASN LEU LYS LYS THR LYS ASP GLY LYS ARG GLU TYR SEQRES 25 A 382 LYS PRO PRO GLY THR ARG LYS LEU HIS ASN ILE LEU GLY SEQRES 26 A 382 VAL GLU THR GLY GLY PRO GLY GLY ARG ARG ALA GLY GLU SEQRES 27 A 382 SER GLY HIS THR VAL ALA ASP TYR LEU LYS PHE LYS ASP SEQRES 28 A 382 LEU ILE LEU ARG MET LEU ASP TYR ASP PRO LYS THR ARG SEQRES 29 A 382 ILE GLN PRO TYR TYR ALA LEU GLN HIS SER PHE PHE LYS SEQRES 30 A 382 LYS THR ALA ASP GLU SEQRES 1 B 382 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 382 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER SER HIS SEQRES 3 B 382 LYS LYS GLU ARG LYS VAL TYR ASN ASP GLY TYR ASP ASP SEQRES 4 B 382 ASP ASN TYR ASP TYR ILE VAL LYS ASN GLY GLU LYS TRP SEQRES 5 B 382 MET ASP ARG TYR GLU ILE ASP SER LEU ILE GLY LYS GLY SEQRES 6 B 382 SER PHE GLY GLN VAL VAL LYS ALA TYR ASP ARG VAL GLU SEQRES 7 B 382 GLN GLU TRP VAL ALA ILE LYS ILE ILE LYS ASN LYS LYS SEQRES 8 B 382 ALA PHE LEU ASN GLN ALA GLN ILE GLU VAL ARG LEU LEU SEQRES 9 B 382 GLU LEU MET ASN LYS HIS ASP THR GLU MET LYS TYR TYR SEQRES 10 B 382 ILE VAL HIS LEU LYS ARG HIS PHE MET PHE ARG ASN HIS SEQRES 11 B 382 LEU CYS LEU VAL PHE GLU MET LEU SER TYR ASN LEU TYR SEQRES 12 B 382 ASP LEU LEU ARG ASN THR ASN PHE ARG GLY VAL SER LEU SEQRES 13 B 382 ASN LEU THR ARG LYS PHE ALA GLN GLN MET CYS THR ALA SEQRES 14 B 382 LEU LEU PHE LEU ALA THR PRO GLU LEU SER ILE ILE HIS SEQRES 15 B 382 CYS ASP LEU LYS PRO GLU ASN ILE LEU LEU CYS ASN PRO SEQRES 16 B 382 LYS ARG SER ALA ILE LYS ILE VAL ASP PHE GLY SER SER SEQRES 17 B 382 CYS GLN LEU GLY GLN ARG ILE TYR GLN PTR ILE GLN SER SEQRES 18 B 382 ARG PHE TYR ARG SER PRO GLU VAL LEU LEU GLY MET PRO SEQRES 19 B 382 TYR ASP LEU ALA ILE ASP MET TRP SER LEU GLY CYS ILE SEQRES 20 B 382 LEU VAL GLU MET HIS THR GLY GLU PRO LEU PHE SER GLY SEQRES 21 B 382 ALA ASN GLU VAL ASP GLN MET ASN LYS ILE VAL GLU VAL SEQRES 22 B 382 LEU GLY ILE PRO PRO ALA HIS ILE LEU ASP GLN ALA PRO SEQRES 23 B 382 LYS ALA ARG LYS PHE PHE GLU LYS LEU PRO ASP GLY THR SEQRES 24 B 382 TRP ASN LEU LYS LYS THR LYS ASP GLY LYS ARG GLU TYR SEQRES 25 B 382 LYS PRO PRO GLY THR ARG LYS LEU HIS ASN ILE LEU GLY SEQRES 26 B 382 VAL GLU THR GLY GLY PRO GLY GLY ARG ARG ALA GLY GLU SEQRES 27 B 382 SER GLY HIS THR VAL ALA ASP TYR LEU LYS PHE LYS ASP SEQRES 28 B 382 LEU ILE LEU ARG MET LEU ASP TYR ASP PRO LYS THR ARG SEQRES 29 B 382 ILE GLN PRO TYR TYR ALA LEU GLN HIS SER PHE PHE LYS SEQRES 30 B 382 LYS THR ALA ASP GLU MODRES 7A55 PTR A 321 TYR MODIFIED RESIDUE MODRES 7A55 PTR B 321 TYR MODIFIED RESIDUE HET PTR A 321 16 HET PTR B 321 16 HET QZ2 A 501 14 HET QZ2 B 501 14 HETNAM PTR O-PHOSPHOTYROSINE HETNAM QZ2 3-(1-METHYLPYRAZOL-4-YL)-1~{H}-PYRAZOLE-5-CARBOXYLIC HETNAM 2 QZ2 ACID HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 QZ2 2(C8 H8 N4 O2) FORMUL 5 HOH *269(H2 O) HELIX 1 AA1 TYR A 136 TYR A 140 5 5 HELIX 2 AA2 LYS A 193 HIS A 213 1 21 HELIX 3 AA3 THR A 215 ILE A 221 5 7 HELIX 4 AA4 ASN A 244 THR A 252 1 9 HELIX 5 AA5 SER A 258 ALA A 277 1 20 HELIX 6 AA6 LYS A 289 GLU A 291 5 3 HELIX 7 AA7 SER A 324 ARG A 328 5 5 HELIX 8 AA8 SER A 329 LEU A 334 1 6 HELIX 9 AA9 LEU A 340 GLY A 357 1 18 HELIX 10 AB1 ASN A 365 GLY A 378 1 14 HELIX 11 AB2 PRO A 381 ASP A 386 1 6 HELIX 12 AB3 LYS A 390 PHE A 394 1 5 HELIX 13 AB4 LYS A 422 LEU A 427 1 6 HELIX 14 AB5 GLY A 433 ARG A 437 5 5 HELIX 15 AB6 THR A 445 LEU A 460 1 16 HELIX 16 AB7 GLN A 469 GLN A 475 1 7 HELIX 17 AB8 HIS A 476 LYS A 480 5 5 HELIX 18 AB9 TYR B 136 TYR B 140 5 5 HELIX 19 AC1 LYS B 193 LYS B 212 1 20 HELIX 20 AC2 GLU B 216 ILE B 221 5 6 HELIX 21 AC3 ASN B 244 THR B 252 1 9 HELIX 22 AC4 SER B 258 THR B 278 1 21 HELIX 23 AC5 LYS B 289 GLU B 291 5 3 HELIX 24 AC6 SER B 324 ARG B 328 5 5 HELIX 25 AC7 SER B 329 LEU B 334 1 6 HELIX 26 AC8 LEU B 340 GLY B 357 1 18 HELIX 27 AC9 ASN B 365 GLY B 378 1 14 HELIX 28 AD1 PRO B 381 ASP B 386 1 6 HELIX 29 AD2 LYS B 390 PHE B 394 1 5 HELIX 30 AD3 LYS B 422 LEU B 427 1 6 HELIX 31 AD4 GLY B 433 ARG B 437 5 5 HELIX 32 AD5 THR B 445 LEU B 460 1 16 HELIX 33 AD6 GLN B 469 GLN B 475 1 7 HELIX 34 AD7 HIS B 476 LYS B 481 5 6 SHEET 1 AA1 6 LYS A 154 TRP A 155 0 SHEET 2 AA1 6 TYR A 159 LYS A 167 -1 O TYR A 159 N TRP A 155 SHEET 3 AA1 6 GLY A 171 ASP A 178 -1 O LYS A 175 N ASP A 162 SHEET 4 AA1 6 GLU A 183 ILE A 190 -1 O ILE A 187 N VAL A 174 SHEET 5 AA1 6 HIS A 233 GLU A 239 -1 O PHE A 238 N ALA A 186 SHEET 6 AA1 6 LEU A 224 PHE A 230 -1 N PHE A 228 O CYS A 235 SHEET 1 AA2 2 ILE A 283 ILE A 284 0 SHEET 2 AA2 2 CYS A 312 GLN A 313 -1 O CYS A 312 N ILE A 284 SHEET 1 AA3 2 ILE A 293 LEU A 295 0 SHEET 2 AA3 2 ILE A 303 ILE A 305 -1 O LYS A 304 N LEU A 294 SHEET 1 AA4 2 PHE A 395 LYS A 397 0 SHEET 2 AA4 2 TRP A 403 LEU A 405 -1 O ASN A 404 N GLU A 396 SHEET 1 AA5 6 LYS B 154 TRP B 155 0 SHEET 2 AA5 6 TYR B 159 GLY B 168 -1 O TYR B 159 N TRP B 155 SHEET 3 AA5 6 GLY B 171 ASP B 178 -1 O LYS B 175 N SER B 163 SHEET 4 AA5 6 GLU B 183 ILE B 190 -1 O ILE B 187 N VAL B 174 SHEET 5 AA5 6 HIS B 233 GLU B 239 -1 O PHE B 238 N ALA B 186 SHEET 6 AA5 6 LEU B 224 PHE B 230 -1 N ARG B 226 O VAL B 237 SHEET 1 AA6 2 ILE B 283 ILE B 284 0 SHEET 2 AA6 2 CYS B 312 GLN B 313 -1 O CYS B 312 N ILE B 284 SHEET 1 AA7 2 ILE B 293 LEU B 295 0 SHEET 2 AA7 2 ILE B 303 ILE B 305 -1 O LYS B 304 N LEU B 294 SHEET 1 AA8 2 PHE B 395 LYS B 397 0 SHEET 2 AA8 2 TRP B 403 LEU B 405 -1 O ASN B 404 N GLU B 396 LINK C GLN A 320 N PTR A 321 1555 1555 1.33 LINK C PTR A 321 N ILE A 322 1555 1555 1.34 LINK C GLN B 320 N PTR B 321 1555 1555 1.34 LINK C PTR B 321 N ILE B 322 1555 1555 1.34 CRYST1 65.383 84.701 76.249 90.00 108.26 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015294 0.000000 0.005045 0.00000 SCALE2 0.000000 0.011806 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013810 0.00000